AN2 Therapeutics Correlations

ANTX Stock

USD 1.37 0.02 1.44%

The current 90-days correlation between AN2 Therapeutics and Bright Minds Biosciences is -0.09 (i.e., Good diversification). The correlation of AN2 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

AN2 Therapeutics Correlation With Market

Average diversification

The correlation between AN2 Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy AN2 Stock please use our How to Invest in AN2 Therapeutics guide.

Moving together with AN2 Stock

0.63

VREX

Varex Imaging Corp

Pair Corr

Moving against AN2 Stock

0.44	IVVD	Invivyd	Pair Corr
0.33	PDSB	PDS Biotechnology Corp	Pair Corr
0.33	PEPG	PepGen	Pair Corr
0.67	APTO	Aptose Biosciences	Pair Corr
0.43	BCYC	Bicycle Therapeutics	Pair Corr
0.34	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.31	COLL	Collegium Pharmaceutical	Pair Corr

Related Correlations Analysis

	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT
DRUG		0.63	0.56	0.64	-0.8	0.81	-0.55	0.72	0.01	DRUG
HPQ	0.63		0.81	0.81	-0.64	0.65	-0.66	0.75	0.03	HPQ
INTC	0.56	0.81		0.81	-0.69	0.62	-0.81	0.65	0.22	INTC
CVX	0.64	0.81	0.81		-0.84	0.7	-0.86	0.87	-0.08	CVX
KO	-0.8	-0.64	-0.69	-0.84		-0.74	0.88	-0.86	0.09	KO
TRV	0.81	0.65	0.62	0.7	-0.74		-0.56	0.75	0.18	TRV
JNJ	-0.55	-0.66	-0.81	-0.86	0.88	-0.56		-0.75	0.04	JNJ
JPM	0.72	0.75	0.65	0.87	-0.86	0.75	-0.75		-0.13	JPM
MSFT	0.01	0.03	0.22	-0.08	0.09	0.18	0.04	-0.13		MSFT
	DRUG	HPQ	INTC	CVX	KO	TRV	JNJ	JPM	MSFT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

JNJ	+ 0.88	KO
JPM	+ 0.87	CVX
TRV	+ 0.81	DRUG
INTC	+ 0.81	HPQ
CVX	+ 0.81	HPQ
CVX	+ 0.81	INTC

High negative correlations

JPM	- 0.86	KO
JNJ	- 0.86	CVX
KO	- 0.84	CVX
JNJ	- 0.81	INTC
KO	- 0.8	DRUG
JPM	- 0.75	JNJ

Risk-Adjusted Indicators

There is a big difference between AN2 Stock performing well and AN2 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AN2 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DRUG	49.12	28.18	2.88	(0.77)	4.62	(58.09)	9.23	(11.87)	1,471
HPQ	1.31	0.03	0.02	0.15	1.62	(1.30)	2.22	(2.63)	6.13
INTC	2.36	0.04	0.07	0.14	2.58	(2.68)	6.36	(3.50)	18.29
CVX	0.90	0.07	0.02	0.22	1.05	(0.93)	2.21	(1.79)	5.13
KO	0.68	(0.15)	0.00	(1.28)	0.00	0.00	1.11	(1.66)	4.00
TRV	1.08	0.15	0.11	0.27	1.17	(1.26)	1.93	(2.17)	11.31
JNJ	0.61	(0.10)	0.00	(0.37)	0.00	0.00	1.40	(1.42)	3.25
JPM	1.12	(0.01)	0.06	0.12	1.42	(1.19)	2.05	(2.00)	15.87
MSFT	0.90	(0.03)	(0.04)	0.07	1.49	(0.86)	2.09	(1.85)	8.19

AN2 Therapeutics Corporate Management

MBA BS	Chief Officer	Profile
Eric Easom	CEO, Cofounder	Profile
Paul MD	Chief Officer	Profile
Sanjay Chanda	Chief Officer	Profile
Josh Eizen	Chief Sec	Profile
Jennifer Huber	Senior Quality	Profile
Michael Alley	CoFounder Biology	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC